{
    "title": "108_s2487",
    "content": "The \"Right Prescription for Seniors Act of 2004\" includes provisions for establishing a Medicare operated plan option, negotiating fair prices for Medicare prescription drugs, and importing prescription drugs. It also sets limitations on prescription drug benefits for Members of Congress. The \"Right Prescription for Seniors Act of 2004\" includes provisions for a Medicare operated plan option, negotiating fair prices for Medicare prescription drugs, and importing prescription drugs. The Secretary will offer a Medicare operated plan option in each PDP region and negotiate with pharmaceutical manufacturers to reduce the purchase cost of covered part D drugs for eligible individuals. The \"Right Prescription for Seniors Act of 2004\" includes provisions for a Medicare operated plan option that offers coverage similar to standard prescription drug coverage and access to negotiated prices for covered part D drugs. The Secretary will implement strategies to reduce purchase costs of these drugs, encouraging the use of more affordable therapeutic equivalents while preserving medical necessity. The \"Right Prescription for Seniors Act of 2004\" includes a Medicare operated plan option with continuous coverage and no coverage gap. The monthly beneficiary premium for the plan is $35 in 2006 and the lesser of the previous year's amount or an annual increase in subsequent years. The \"Right Prescription for Seniors Act of 2004\" offers a Medicare plan with continuous coverage and a monthly premium of $35 in 2006. The premium increases annually based on the percentage increase in drug expenditures for beneficiaries in the US. The \"Right Prescription for Seniors Act of 2004\" provides a Medicare plan with a monthly premium that increases annually. The specified amount for each year is outlined, and the medicare operated plan option is in addition to the plans required under subsection (d)(1). Conforming amendments are made to section 1860D-3 of the Social Security Act. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003 (Public Law 108-173) repeals section 101(a). Section 1860D-11(f) of the Social Security Act is amended to include conditions for approval of limited risk plans in PDP regions. The Secretary must ensure that each part D eligible individual has a choice of enrollment in at least 2 qualifying plans in their area, with at least one being a prescription drug plan. The requirement is not met if only one entity offers all the qualifying plans in the area. The term 'qualifying plan' in this section refers to a prescription drug plan or an MA-PD plan that offers basic or supplemental prescription drug coverage without charging a monthly supplemental beneficiary premium. Section 1860D-11 of the Medicare Prescription Drug, Improvement, and Modernization Act is amended to replace references to \"fallback prescription drug plan\" with \"medicare operated plan option\" and to require the Secretary to submit an annual report on limited risk plans offered under subsection (f). The amendments to the Social Security Act include removing and redesignating paragraphs, as well as striking subsections. The effective date for these changes is retroactive to the enactment of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003. SEC. 3. Negotiating fair prices for Medicare prescription drugs. Section 1860D-11 of the Social Security Act is amended to give the Secretary authority to negotiate prices with manufacturers of covered part D drugs to ensure beneficiaries pay the lowest possible price. The Secretary has authority to negotiate prices with manufacturers of part D drugs for beneficiaries under prescription drug plans offered by PDP sponsors. SEC. 4. IMPORTATION OF PRESCRIPTION DRUGS. Section 804 of the Federal Food, Drug, and Cosmetic Act is amended to include pharmacists, wholesalers, and qualifying individuals in the regulations for imported products. Compliance with sections 501, 502, and 505 of the Act is required for imported covered products. The Federal Food, Drug, and Cosmetic Act is amended to include regulations for imported products, specifying requirements for pharmacists, wholesalers, and qualifying individuals. This includes compliance with sections 501, 502, and 505 of the Act for imported covered products. The Federal Food, Drug, and Cosmetic Act is amended to include regulations for imported products, specifying requirements for pharmacists, wholesalers, and qualifying individuals. This includes compliance with sections 501, 502, and 505 of the Act for imported covered products. Subsection (e) is updated to include testing regulations. Regulations under subsection (e) require testing by importers of covered products, except for prescription drugs subject to specific requirements. Testing requirements do not apply to importers who are wholesalers. Subsection (f) is amended by removing certain limitations, and subsection (g) is updated to remove references to counterfeiting. The Secretary will conduct a study on imports permitted under subsection (a) to evaluate compliance. The Secretary will evaluate importers' compliance with regulations and the incidence of misbranded or adulterated shipments. This will be compared to the incidence of misbranded or adulterated prescription drugs transported within the United States. The Pharmaceutical Market Access Act of 2003 amends various subsections, including defining a \"qualifying individual\" as someone who is not a pharmacist or wholesaler, and removing subsections (l) and (m) within 18 months of enactment. SEC. 5. LIMITATION ON PRESCRIPTION DRUG BENEFITS OF MEMBERS OF CONGRESS. The actuarial value of prescription drug benefits for Members of Congress enrolled in a health benefits plan under chapter 89 of title 5, United States Code, cannot exceed basic prescription drug coverage. The Director of the Office of Personnel Management will create regulations for this section."
}